financetom
Business
financetom
/
Business
/
Tata Motors considers up to 1-year extension for Guenter Butschek
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tata Motors considers up to 1-year extension for Guenter Butschek
Jun 16, 2021 1:59 PM

Tata Motors is considering granting a further extension of up to one year to Guenter Butschek, as the company's search for the next managing director is yet come to fruition.

Parikshit Luthra reports that Butschek was previously given an extension till June 30 after Marc Llistosella declined to join as MD citing personal reasons. Global consultancy firm Egon Zehnder has been hired to advice the company on leadership succession and possible candidates.

Watch video for more.

(Edited by : Bivekananda Biswas)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
National Bank Maintains Transat Underperform Rating, $2.25 Target After Q2 Result
National Bank Maintains Transat Underperform Rating, $2.25 Target After Q2 Result
Jun 6, 2024
01:47 PM EDT, 06/06/2024 (MT Newswires) -- National Bank is maintaining its Underperform rating and $2.25 target on Transat following its second quarter results. Analyst Cameron Doerksen writes that in mid-May, Transat lowered its F2024 EBITDA margin expectation to ~5% from prior guidance of 7.5%-9% driven by challenges related to engine-related aircraft groundings, the impact from strike threats, and generally...
Exclusive-Chile's Codelco targeting 2030 production for Maricunga lithium site -document
Exclusive-Chile's Codelco targeting 2030 production for Maricunga lithium site -document
Jun 6, 2024
SANTIAGO (Reuters) - Rothschild & Co has formally started to assess candidates to partner with Chile's state-run miner Codelco on a major new lithium project slated to begin production in 2030, according to documents seen by Reuters on Thursday. A four-page investment highlight document from Codelco and Rothschild, dated June 2024, and accompanying memo, reveal new details of Codelco's plans...
--Bank7 Keeps Quarterly Dividend at $0.21 a Share, Payable July 9 to Shareholders of Record June 20
--Bank7 Keeps Quarterly Dividend at $0.21 a Share, Payable July 9 to Shareholders of Record June 20
Jun 6, 2024
01:48 PM EDT, 06/06/2024 (MT Newswires) -- Price: 29.95, Change: -0.65, Percent Change: -2.12 ...
Arbutus Biopharma Says Imdusiran Plus VTP-300 Therapy Lowers HBsAg Levels in Trial
Arbutus Biopharma Says Imdusiran Plus VTP-300 Therapy Lowers HBsAg Levels in Trial
Jun 6, 2024
01:49 PM EDT, 06/06/2024 (MT Newswires) -- Arbutus Biopharma ( ABUS ) said Thursday data from a phase 2a trial in patients with chronic hepatitis B virus infection showed that treatment with imdusiran followed by Barinthus Biotherapeutics' ( BRNS ) VTP-300 was generally safe and well-tolerated. Based on preliminary end-of-treatment data, Arbutus said that the therapy resulted in maintenance of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved